Sommario

• • ·Keeping the G8 spotlight on Africa

    Pagina :457

     
• • ·Development of vaccines against influenza H5

    Pagina :458-460

    Iain Stephenson, Ian Gust, Yuri Pervikov, Marie Paule Kieny

     
• • ·Moving up from 3 by 5

    Pagina :460-461

    Marcel Stoeckle, Rehema Mchomvu, Christoph Hatz, Manuel Battegay, Eric A Aris, Hassan Mshinda, Marcel Tanner

     
• • ·The immunopathogenesis of mycobacterial immune restoration disease

    Pagina :461-462

    Martyn A French

     
• • ·Aedes albopictus as an epidemic vector of chikungunya virus: another emerging problem?

    Pagina :463-464

    Paul Reiter, Didier Fontenille, Christophe Paupy

    
• • ·Tenacity at the biological gym

    Pagina :465

    Bernard Dixon

     
• • ·AIDS treatment enters its 25th year

    Pagina :466-467

    Roxanne Nelson

     
• • ·Buffett gift will benefit global health and disease research

    Pagina :468

    Marilynn Larkin

     
• • ·New tools for preventing HPV infections

    Pagina :468-469

    Roxanne Nelson

    
• • ·New infectious diseases centre opens in China

    Pagina :469

    Margaret Harris Cheng

     
• • ·Malaria death due to fake drugs deemed “manslaughter”

    Pagina :470

    Kelly Morris

    
• • ·SARS case was influenza H5N1

    Pagina :470

    Khabir Ahmad

    
• • ·South African methamphetamine boom could fuel further HIV

    Pagina :471

    Kelly Morris, Charles Parry

     
• • ·New antibiotic relabelled after liver damage link

    Pagina :471

    Kathryn Senior

    
• • ·Antibiotics for bronchitis and hospital admissions

    Pagina :472

    Emma Wilkinson

    
• • ·Chlorhexidine could cut risk of pneumonia in intensive care

    Pagina :472

    Katherine Nightingale

    
• • ·Research brief

    Pagina :473

    Jane Bradbury

    Mappa Mappa  
• • ·Infectious disease surveillance update

    Pagina :474

    Pam Das

    Mappa Mappa  
• • ·HIV and older people: a growing concern

    Pagina :475

    Marilynn Larkin

    Mappa Mappa
• • ·The Age of AIDS

    Pagina :476

    Talha Burki

    
• • ·Erratum

    Pagina :476

    
• • ·J-P Garnier—Chief Executive Officer of GlaxoSmithKline

    Pagina :477-482

    Pam Das

     
• • ·Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration

    Pagina :483-495

    Alasdair Reid, Fabio Scano, Haileyesus Getahun, Brian Williams, Christopher Dye, Paul Nunn, Kevin M De Cock, Catherine Hankins, Bess Miller, Kenneth G Castro, Mario C Raviglione

    Riassunto Riassunto Mappa Mappa  
• • ·Approach to salvage antiretroviral therapy in heavily antiretroviral-experienced HIV-positive adults

    Pagina :496-507

    Zelalem Temesgen, Francesca Cainelli, Eric M Poeschla, Stacey AR Vlahakis, Sandro Vento

    Riassunto Riassunto Mappa Mappa
• • ·Containing HIV/AIDS in India: the unfinished agenda

    Pagina :508-521

    Padma Chandrasekaran, Gina Dallabetta, Virginia Loo, Sujata Rao, Helene Gayle, Ashok Alexander

    Riassunto Riassunto Mappa Mappa  
• • ·Early clinical trials with a new tuberculosis vaccine, MVA85A, in tuberculosis-endemic countries: issues in study design

    Pagina :522-528

    Hannah B Ibanga, Roger H Brookes, Philip C Hill, Patrick K Owiafe, Helen A Fletcher, Christian Lienhardt, Adrian VS Hill, Richard A Adegbola, Helen McShane

    Riassunto Riassunto Mappa Mappa  
• • ·Problem pathogens: paediatric legionellosis—implications for improved diagnosis

    Pagina :529-535

    David Greenberg, Christine C Chiou, Ronald Famigilleti, Tzielan C Lee, Victor L Yu

    Riassunto Riassunto Mappa Mappa
• • ·Cutaneous mucormycosis in an immunocompromised patient

    Pagina :536

    BC Becker, FR Schuster, B Ganster, HP Seidl, I Schmid